HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Managing drug shortages during a pandemic: tocilizumab and COVID-19.

AuthorsAmol A Verma, Menaka Pai, Sudipta Saha, Sally Bean, Michael Fralick, Jennifer L Gibson, Rebecca A Greenberg, Janice L Kwan, Lauren Lapointe-Shaw, Terence Tang, Andrew M Morris, Fahad Razak
JournalCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne (CMAJ) Vol. 193 Issue 21 Pg. E771-E776 (05 25 2021) ISSN: 1488-2329 [Electronic] Canada
PMID33952621 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal, Humanized
  • Antiviral Agents
  • tocilizumab
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal, Humanized (therapeutic use)
  • Antiviral Agents (therapeutic use)
  • COVID-19 (diagnosis, mortality, therapy)
  • Critical Care (methods)
  • Drug Industry (organization & administration)
  • Female
  • Health Care Rationing (methods, organization & administration)
  • Health Resources (supply & distribution)
  • Health Services Accessibility (organization & administration)
  • Humans
  • Male
  • Middle Aged
  • Ontario (epidemiology)
  • Pandemics
  • Respiration, Artificial
  • Severity of Illness Index
  • Treatment Outcome
  • COVID-19 Drug Treatment

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: